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Percutaneous Approach for Human Islet Transplantation 
H.L.R. Rilo, K. Bron, A. Tzakis, P. Fontes, P. Carroll, R. Shapiro, T.E. Starzl, and C. Ricordi 
THIS report describes the application of the percutane-
ous approach for islet cell infusion into the portal 
system. Percutaneous transhepatic puncture and catheter-
ization of the portal vein is a widely accepted radiographic 
method, which is currently used in diagnostic and thera-
peutic procedures. J 
MATERIALS AND METHODS 
Two male patients. aged 29 and 36 years. received combined 
cadaveric kidney-islet grafts for end-stage renal disease secondary 
to type I diabetes mellitus. The kidneys and pancreas were 
obtained from multiorgan donor procurement.2 The organs were 
preserved in UW solution and packed on ice. The pancreas ofthe 
kidney donor was the source of the primary islet allograft in the 
29-year-old patient. A second islet preparation was infused 2 days 
later by the percutaneous approach. The 36-year·old recipient 
received a kidney allograft and islets from a different donor 8 days 
after the kidney transplant. The human islet preparation were 
obtained by a modificationJ of the automated method4 for human 
islet isolation. After documentation of patency of the portal vein 
by Doppler ultrasonography the right midaxillary line and the 
tenth or eleventh rib interspace were used as landmarks to locate 
peripheral portal vein branches. After prepping the skin in this 
area with betadine solution, the interspace was palpated and 
anesthetized with 2% lidocaine. A short skin incision was made 
and a 22-gauge Chiba needle was introduced into the liver via the 
incision in the midaxillary line. The needle was passed through the 
parenchyma in the coronal plane to the edge of the spine. A portal 
vein branch was isolated by injecting radiopaque contrast (iopa-
midole 3(0) through the Chiba needle while slowly withdrawing 
the needle. The position of the needle and the contrast injection 
were observed ftuoroscopicaliy. A portal vein branch was identi-
fied by observing the pattern of distribution of contrast.5-7 When 
the branch was identified. a O.18-in steel guide was introduced 
through the needle lumen. A 4F or 5F catheter was passed over 
the guide wire through the liver parenchyma into the lumen of the 
portal vein. Radiopaque contrast was injected through the cathe-
ter and an angiogram was obtained to outline the anatomy of the 
intra- and extrahepatic portal vein (Fig 1). The pancreatic islet 
cells were then slowly infused by gravity through the catheter into 
the main portal vein.- The islet infusion lasted 10 to 20 minutes. 
There were no complications. When the infusion was completed. 
the catheter was withdrawn and the patient was kept at bed rest 
for 3 hours with periodic monitoring of the vital signs and 
hematocrit. 
RESULTS AND DISCUSSION 
The percutaneous approach for intraportal islet infusion 
was uneventful and well tolerated in both patients. The 
procedure is readily accessible and could allow to perform 
intrahepatic cell transplants without the need for pro-
longed hospitalization or laparotomy. We were unable to 
find any detailed description of this approach, even though 
it has been used in several patients undergoing allotrans-
Fig 1. Angiogram outlining the anatomy of the intra- and extra-
hepatic portal vein. 
plantation,s autograft,9 and pig-to-human xenografts 
(Groth et al, presented at the Third International Congress 
on Pancreatic and Islet Transplantation. Lyon, 1991). The 
percutaneous approach could be of assistance in those 
cases in which the islet transplant is performed after an 
established kidney allograft or in cases in which multiple 
donors are used. 
In the future, if islet transplantation becomes feasible 
before the requirement for kidney transplant, the percuta-
neous approach could allow the islet implant to be per-
formed as an outpatient procedure. 
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